Advanced search
Publication Cover
Acta Orthopaedica Volume 85, 2014 - Issue 1
Journal homepage
728
Views
1
CrossRef citations to date
0
Altmetric
Spine, shoulder and hand

Expression of gap junction proteins connexins 26, 30, and 43 in Dupuytren’s disease

Lukas A HolzerDepartment of Orthopaedic Surgery, Medical University of Graz, Graz, Austria
,
Andrej CörFaculty of Health Sciences, University of Primorska, University of Primorska, Izola, Slovenia
&
Gerold HolzerDepartment of Orthopaedics, Medical University of Vienna, Vienna, AustriaCorrespondence[email protected]
Pages 97-101 | Received 09 Jul 2013, Accepted 02 Nov 2013, Published online: 20 Dec 2013

  • Becker DL, Thrasivoulou C, Phillips AR. Connexins in wound healing; perspectives in diabetic patients. Biochim Biophys Acta 2012; 1818: 2068-75.
  • Brandner JM, Houdek P, Husing B, Kaiser C, Moll I. Connexins 26, 30, and 43: differences among spontaneous, chronic, and accelerated human wound healing. J Invest Dermatol 2004; 122: 1310–20.
  • Burge P, Hoy G, Regan P, Milne R. Smoking, alcohol and the risk of Dupuytren’s contracture. J Bone Joint Surg (Br) 1997; 79: 206–10.
  • Churko JM, Laird DW. Gap junction remodeling in skin repair following wounding and disease. Physiology (Bethesda) 2013; 28: 190-8.
  • Coutinho P, Qiu C, Frank S, Tamber K, Becker D. Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol Int 2003; 27: 525–41.
  • Davis NG, Phillips A, Becker DL. Connexin dynamics in the privileged wound healing of the buccal mucosa. Wound Repair Regen 2013; 21: 571-8
  • Dolmans GH, Werker PM, Hennies HC, Furniss D, Festen EA, Franke L, Becker K, van der Vlies P, Wolffenbuttel BH, Tinschert S, Toliat MR, Nothnagel M, Franke A, Klopp N, Wichmann HE, Nürnberg P, Giele H, Ophoff RA, Wijmenga C. Wnt signaling and Dupuytren’s disease. N Engl J Med 2011; 365: 307-17.
  • Goliger JA, Paul DL. Wounding alters epidermal connexin expression and gap junction-mediated intercellular communication. Mol Biol Cell 1995; 6: 1491–501.
  • Holzer LA, Cör A, Pfandlsteiner G, Holzer G. Expression of VEGF, its receptors and HIF-1α in Dupuytren’s disease. Acta Orthop 2013; 84: 420-5
  • Howard JC, Varallo VM, Ross DC, Faber KJ, Roth JH, Seney S, Gan BS. Wound healing-associated proteins Hsp47 and fibronectin are elevated in Dupuytren’s contracture. J Surg Res 2004; 117: 232–8.
  • Iselin M, Dieckmann GD. Therapy of Dupuytren’s contracture with total zigzag plastic surgery. Presse Med 1951; 59: 1394–5.
  • Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, Srisakuldee W, Makazan J, Tanguy S, Spray DC. The role of connexins in controlling cell growth and gene expression. Prog Biophys Mol Biol 2007; 94: 245–64.
  • Kumar MN, Gilula NB. The gap junction communication channel. Cell 1996; 84: 381–8.
  • Lemaître G, Sivan V, Lamartine J, Cosset JM, Cavelier-Balloy B, Salomon D, Waksman G, Martin MT. Connexin 30, a new marker of hyperproliferative epidermis. Br J Dermatol 2006; 155: 844-6.
  • Luck JV. Dupuytren’s contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg (Am) 1959; 41: 635–64.
  • Mese G, Richard G, White TW Gap junctions: basic structure and function. J Invest Dermatol 2007; 127: 2516–24.
  • Mori R, Power KT, Wang CM, Martin P, Becker D. Acute downregulation of connexin43 at wound sites leads to reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci 2006; 119: 5193–203.
  • Pollok S, Pfeiffer AC, Lobmann R, Wright CS, Moll I, Martin PE, Brandner JM. Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells. J Cell Mol Med 2011; 15: 861–73.
  • Qiu C, Coutinho P, Frank S, Franke S, Law LY, Martin P, Green CR, Becker DL. Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 2003; 13: 1697–703.
  • Rayan GM. Dupuytren Disease: Anatomy, pathology, presentation, and treatment. J Bone Joint Surg (Am) 2007; 89: 189-98.
  • Shih B, Bayat A. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol 2010; 6: 715-26.
  • Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349–63.
  • Verhoekx J, Verjee LS, Izadi D, Chan J KK, Nicolaidou V, Davidson D, Midwood KS, Nanchahal J. Isometric Contraction of Dupuytren’s Myofibroblasts is Inhibited by Blocking Intercellular Junctions. J Investig Dermatol 2013; 133(12): 2664-71.
  • Verjee LS, Midwood K, Davidson D, Essex D, Sandison A, Nanchahal J. Myofibroblast distribution in Dupuytren’s cords: correlation with digital contracture. J Hand Surg Am 2009; 34: 1785-94.
  • Wright CS, van Steensel M AM, Hodgins MB, Martin P ME. Connexin mimetic peptides improve cell migration rates of human epidermal keratinocytes and dermal fibroblasts in vitro. Wound Rep Reg 2009; 17: 240–9.
  • Xu J, Nicholson BJ. The role of connexins in ear and skin physiology— Functional insights from disease-associated mutations. Biochim Biophys Acta 2013; 1828: 167–78.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.